Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
April-2018 Volume 52 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2018 Volume 52 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma

  • Authors:
    • Hakushi Kim
    • Chie Inomoto
    • Takato Uchida
    • Hiroyuki Furuya
    • Tomoyoshi Komiyama
    • Hiroshi Kajiwara
    • Hiroyuki Kobayashi
    • Naoya Nakamura
    • Akira Miyajima
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan, Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan, Department of Preventive Medicine, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan, Department of Clinical Pharmacology, Tokai University School of Medicine, Isehara, Kanagawa 259-1193, Japan
    Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1139-1148
    |
    Published online on: February 28, 2018
       https://doi.org/10.3892/ijo.2018.4294
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to evaluate the validity of potential prognostic parameters of clear cell renal cell carcinoma (ccRCC) recommended by the 2012 International Society of Urological Pathology (ISUP) Consensus Conference in the Japanese population. We reviewed 406 Japanese patients with localized or locally advanced ccRCC who underwent curative surgery during 2004-2014 at Tokai University Hospital (Isehara, Japan) and were followed up for >2 years after surgery. A single pathologist reviewed all the histological slides. Morphological subtype and pathological T stage were reassigned according to the 2016 World Health Organization and TNM classifications. Sarcomatoid differentiation (SD), rhabdoid differentiation (RD), tumor necrosis (TN) and microvascular invasion (MVI) were assessed according to the 2012 ISUP recommendations. Nuclear grade was reclassified according to both the Fuhrman and the ISUP grading systems. Recurrence‑free survival (RFS) and cancer-specific survival (CSS) were assessed through univariate and multivariate analyses. According to the Fuhrman grading system (group Fuhrman), TN and MVI were independent risk factors for postoperative recurrence in the multivariate analysis using the Cox proportional hazards model. According to the ISUP grading system (group ISUP), TN and MVI were independent risk factors for postoperative recurrence. In group Fuhrman, age, Fuhrman grade and TN were independent risk factors for CSS. In group ISUP, age, ISUP grade, and TN were independent risk factors for CSS. Furthermore, the group that was upgraded from Fuhrman grade 2 to ISUP grade 3 exhibited poorer CSS compared with the group that was reclassified from Fuhrman grade 2 to ISUP grade 2 (non-upgraded). Regardless of the nuclear grade, TN remained an independent predictor of RFS and CSS. To the best of our knowledge, this is the first report to prove the correlation between the 2012 ISUP recommendations and clinical outcomes in a Japanese ccRCC cohort. TN and upgrading to ISUP grade 3 were found to be potentially useful independent indicators of postoperative prognosis.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar

2 

Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A and Bray F: International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol. 67:519–530. 2015. View Article : Google Scholar

3 

Moch H, Gasser T, Amin MB, Torhorst J, Sauter G and Mihatsch MJ: Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: A Swiss experience with 588 tumors. Cancer. 89:604–614. 2000. View Article : Google Scholar : PubMed/NCBI

4 

Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, Deshpande A and Menon M: Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol. 26:281–291. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Ficarra V, Martignoni G, Galfano A, Novara G, Gobbo S, Brunelli M, Pea M, Zattoni F and Artibani W: Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol. 50:786–793; discussion 793–794. 2006. View Article : Google Scholar : PubMed/NCBI

6 

Delahunt B, Cheville JC, Martignoni G, Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch H, Grignon DJ, et al: Members of the ISUP Renal Tumor Panel: The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol. 37:1490–1504. 2013. View Article : Google Scholar : PubMed/NCBI

7 

Lee SE, Byun SS, Oh JK, Lee SC, Chang IH, Choe G and Hong SK: Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J Urol. 176:1332–1337; discussion 1337–1338. 2006. View Article : Google Scholar : PubMed/NCBI

8 

Katz MD, Serrano MF, Grubb RL III, Skolarus TA, Gao F, Humphrey PA and Kibel AS: Percent microscopic tumor necrosis and survival after curative surgery for renal cell carcinoma. J Urol. 183:909–914. 2010. View Article : Google Scholar : PubMed/NCBI

9 

Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL and Zincke H: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score. J Urol. 168:2395–2400. 2002. View Article : Google Scholar : PubMed/NCBI

10 

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Kampel-Kettner K, Rehak P, Pummer K and Zigeuner R: Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol. 137:283–289. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, et al: Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer. 103:2517–2525. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Sengupta S, Lohse CM, Leibovich BC, Frank I, Thompson RH, Webster WS, Zincke H, Blute ML, Cheville JC and Kwon ED: Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer. 104:511–520. 2005. View Article : Google Scholar : PubMed/NCBI

13 

Ficarra V, Martignoni G, Lohse C, Novara G, Pea M, Cavalleri S and Artibani W: External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol. 175:1235–1239. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Delahunt B, Sika-Paotonu D, Bethwaite PB, William Jordan T, Magi-Galluzzi C, Zhou M, Samaratunga H and Srigley JR: Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol. 35:1134–1139. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Cheville JC, Lohse CM, Zincke H, Weaver AL and Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 27:612–624. 2003. View Article : Google Scholar : PubMed/NCBI

16 

Kim H, Cho NH, Kim DS, Kwon YM, Kim EK, Rha SH, Park YW, Shim JW, Lee SS, Lee SN, et al: Genitourinary Pathology Study Group of the Korean Society of Pathologists: Renal cell carcinoma in South Korea: A multicenter study. Hum Pathol. 35:1556–1563. 2004. View Article : Google Scholar : PubMed/NCBI

17 

Thompson RH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML and Frank I: Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: The D-SSIGN score. J Urol. 177:477–480. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Isbarn H, Patard JJ, Lughezzani G, Rioux-Leclercq N, Crépel M, Cindolo L, de la Taille A, Zini L, Villers A, Shariat SF, et al: Limited prognostic value of tumor necrosis in patients with renal cell carcinoma. Urology. 75:1378–1384. 2010. View Article : Google Scholar

19 

Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI

20 

Delahunt B: Advances and controversies in grading and staging of renal cell carcinoma. Mod Pathol. 22(Suppl 2): S24–S36. 2009.PubMed/NCBI

21 

Goldstein NS: Grading of renal cell carcinoma. Urol Clin North Am. 26:637–642, vii. 1999. View Article : Google Scholar : PubMed/NCBI

22 

Lang H, Lindner V, de Fromont M, Molinié V, Letourneux H, Meyer N and Martin M: Jacqmin D. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up. Cancer. 103:625–629. 2005. View Article : Google Scholar

23 

Lanigan D, Conroy R, Barry-Walsh C, Loftus B, Royston D and Leader M: A comparative analysis of grading systems in renal adenocarcinoma. Histopathology. 24:473–476. 1994. View Article : Google Scholar : PubMed/NCBI

24 

Delahunt B, Bethwaite PB and Nacey JN: Outcome prediction for renal cell carcinoma: Evaluation of prognostic factors for tumours divided according to histological subtype. Pathology. 39:459–465. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Pichler M, Hutterer GC, Chromecki TF, Jesche J, Groselj-Strele A, Kampel-Kettner K, Pummer K and Zigeuner R: Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma. J Urol. 187:834–839. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Cho HJ, Kim SJ, Ha US, Hong SH, Kim JC, Choi YJ and Hwang TK: Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma. Eur Urol. 56:1006–1012. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Sevinç M, Kirkali Z, Yörükoğlu K, Mungan U and Sade M: Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol. 38:728–733. 2000. View Article : Google Scholar : PubMed/NCBI

28 

Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B and Baert L: Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol. 158:45–49. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Roos FC, Weirich J, Victor A, Elsässer A, Brenner W, Biesterfeld S, Hampel C and Thüroff JW: Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma. BJU Int. 104:461–469. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Lang H, Lindner V, Letourneux H, Martin M, Saussine C and Jacqmin D: Prognostic value of microscopic venous invasion in renal cell carcinoma: Long-term follow-up. Eur Urol. 46:331–335. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Kim H, Inomoto C, Uchida T, Furuya H, Komiyama T, Kajiwara H, Kobayashi H, Nakamura N and Miyajima A: Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. Int J Oncol 52: 1139-1148, 2018.
APA
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H. ... Miyajima, A. (2018). Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. International Journal of Oncology, 52, 1139-1148. https://doi.org/10.3892/ijo.2018.4294
MLA
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H., Kobayashi, H., Nakamura, N., Miyajima, A."Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma". International Journal of Oncology 52.4 (2018): 1139-1148.
Chicago
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H., Kobayashi, H., Nakamura, N., Miyajima, A."Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma". International Journal of Oncology 52, no. 4 (2018): 1139-1148. https://doi.org/10.3892/ijo.2018.4294
Copy and paste a formatted citation
x
Spandidos Publications style
Kim H, Inomoto C, Uchida T, Furuya H, Komiyama T, Kajiwara H, Kobayashi H, Nakamura N and Miyajima A: Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. Int J Oncol 52: 1139-1148, 2018.
APA
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H. ... Miyajima, A. (2018). Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma. International Journal of Oncology, 52, 1139-1148. https://doi.org/10.3892/ijo.2018.4294
MLA
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H., Kobayashi, H., Nakamura, N., Miyajima, A."Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma". International Journal of Oncology 52.4 (2018): 1139-1148.
Chicago
Kim, H., Inomoto, C., Uchida, T., Furuya, H., Komiyama, T., Kajiwara, H., Kobayashi, H., Nakamura, N., Miyajima, A."Verification of the International Society of Urological Pathology recommendations in Japanese patients with clear cell renal cell carcinoma". International Journal of Oncology 52, no. 4 (2018): 1139-1148. https://doi.org/10.3892/ijo.2018.4294
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team